These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 15216448

  • 1. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
    Hermanns N, Burkert A, Haak T.
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):310-4. PubMed ID: 15216448
    [Abstract] [Full Text] [Related]

  • 2. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C, Hofmann U, Paulwitz O.
    Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
    [Abstract] [Full Text] [Related]

  • 3. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C, Haupt E, Walter T, Werner J.
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [Abstract] [Full Text] [Related]

  • 4. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H, Höxter G.
    Fortschr Med; 1994 Nov 20; 112(32):467-70. PubMed ID: 7821886
    [Abstract] [Full Text] [Related]

  • 5. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH.
    Clin Ther; 2006 Oct 20; 28(10):1649-57. PubMed ID: 17157120
    [Abstract] [Full Text] [Related]

  • 6. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.
    Juntti-Berggren L, Pigon J, Hellström P, Holst JJ, Efendic S.
    Diabetes Nutr Metab; 2000 Feb 20; 13(1):7-12. PubMed ID: 10824717
    [Abstract] [Full Text] [Related]

  • 7. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH, Wudy A, Eberlein G, Quast C.
    Diabetes Nutr Metab; 1999 Jun 20; 12(3):195-201. PubMed ID: 10554902
    [Abstract] [Full Text] [Related]

  • 8. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, McGill J.
    Diabetes Care; 2006 Sep 20; 29(9):2095-101. PubMed ID: 16936159
    [Abstract] [Full Text] [Related]

  • 9. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.
    Diabetes Metab Res Rev; 2004 Sep 20; 20(1):55-60. PubMed ID: 14737746
    [Abstract] [Full Text] [Related]

  • 10. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A, Home PD.
    Diabetes Res Clin Pract; 2005 Mar 20; 67(3):196-203. PubMed ID: 15713351
    [Abstract] [Full Text] [Related]

  • 11. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.
    J Diabetes Complications; 2007 Mar 20; 21(1):20-7. PubMed ID: 17189870
    [Abstract] [Full Text] [Related]

  • 12. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H, Kothare PA, Skrivanek Z, de la Peña A, Atkins M, Ernest CS, Trautmann ME.
    Diabet Med; 2006 Mar 20; 23(3):240-5. PubMed ID: 16492205
    [Abstract] [Full Text] [Related]

  • 13. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
    Luzio S, Peter R, Dunseath GJ, Mustafa L, Owens DR.
    Diabetes Res Clin Pract; 2008 Feb 20; 79(2):269-75. PubMed ID: 18164094
    [Abstract] [Full Text] [Related]

  • 14. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
    Domke A, Willms B.
    Med Klin (Munich); 1994 Apr 15; 89(4):187-92. PubMed ID: 8015532
    [Abstract] [Full Text] [Related]

  • 15. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF, Zhao LB, Li XY, Wang WQ, Sun SY, Chen YH, Hong J, Su TW, Liu JM, Ning G.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1700-3. PubMed ID: 17935674
    [Abstract] [Full Text] [Related]

  • 16. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
    Soonthornpun S, Rattarasarn C, Thamprasit A, Leetanaporn K.
    J Med Assoc Thai; 1998 Mar 05; 81(3):195-200. PubMed ID: 9623011
    [Abstract] [Full Text] [Related]

  • 17. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S, Turco S, Guarino G, Oliviero B, Rustici A, Torella R.
    Ann Ital Med Int; 1999 Mar 05; 14(1):7-14. PubMed ID: 10528419
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J, Soszyński P.
    Przegl Lek; 1999 Mar 05; 56(5):335-41. PubMed ID: 10554569
    [Abstract] [Full Text] [Related]

  • 19. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.
    Clin Ther; 2008 May 05; 30(5):858-67. PubMed ID: 18555933
    [Abstract] [Full Text] [Related]

  • 20. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
    Skrha J, Smahelová A, Andĕl M, Vrtovec M, Subić J, Kreze A, Vozar J, Korecová M, de Verga V, Wyatt J, Metcalfe S, Ristić S.
    Sb Lek; 2002 May 05; 103(1):15-21. PubMed ID: 12448933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.